Intranasal steroid spray vs placebo or no intervention
Prevalence of parosmia · people with olfactory dysfunction for less than 4 weeks following COVID‐19 infection
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for the prevention of persistent post‐COVID‐19 olfactory dysfunction 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found